Colgate-Palmolive Shares Face Persistent Headwinds Despite Earnings Beat

Consumer products heavyweight Colgate-Palmolive finds itself navigating turbulent market conditions. The stock has declined approximately 24% since the start of the year as investors weigh mixed financial performance against challenging operational headwinds. While recent quarterly earnings surpassed expectations, underlying margin pressures and revised growth projections continue to cloud the investment outlook.

Margin Compression Overshadows Earnings Surprise

Colgate-Palmolive’s third-quarter performance presented a complex picture for market participants. The company reported earnings per share of $0.91, exceeding analyst forecasts, but this positive development was tempered by concerning underlying trends. Revenue reached $5.13 billion, falling short of market expectations, while adjusted gross margin contracted by 190 basis points to 59.4%. This profitability squeeze stems primarily from escalating costs for raw and packaging materials, creating significant pressure on the company’s core product lines.

Revised Guidance Alarms Investment Community

Perhaps more concerning to shareholders was management’s decision to substantially lower future growth expectations. Colgate-Palmolive now anticipates organic revenue growth of just 1-2% for 2025, down significantly from the previously projected range of 2-4%. This downward revision reflects multiple challenges: consumer resistance to higher pricing and additional cost pressures from tariffs amounting to approximately $75 million. The guidance adjustment has prompted both retail and institutional investors to reconsider their positions, with several major funds reportedly reducing exposure.

Should investors sell immediately? Or is it worth buying Colgate-Palmolive?

Analyst Community Maintains Cautious Stance

Despite these operational challenges, research analysts generally maintain a “Moderate Buy” recommendation on Colgate-Palmolive shares, though with notably reduced price targets. Financial institutions including Goldman Sachs, Wells Fargo, and Bank of America have all trimmed their expectations, pulling the average price target down to $89.87. The company’s dividend, which currently yields 2.6%, provides some defensive appeal during this period of uncertainty, offering income-oriented investors partial compensation for the stock’s weakness.

Market observers now question whether the company’s newly announced multi-year productivity initiative can sufficiently streamline operations and fund necessary innovation to reverse the current negative trajectory. The program’s effectiveness in addressing both cost structure challenges and growth acceleration will likely determine Colgate-Palmolive’s ability to break its downward trend.